nodes	percent_of_prediction	percent_of_DWPC	metapath
Bismuth Subsalicylate—PTGS1—Ifosfamide—testicular cancer	0.216	0.35	CbGbCtD
Bismuth Subsalicylate—PTGS2—Cisplatin—testicular cancer	0.125	0.202	CbGbCtD
Bismuth Subsalicylate—PTGS2—Etoposide—testicular cancer	0.122	0.198	CbGbCtD
Bismuth Subsalicylate—PTGS1—Etoposide—testicular cancer	0.103	0.167	CbGbCtD
Bismuth Subsalicylate—TF—seminiferous tubule of testis—testicular cancer	0.0763	0.459	CbGeAlD
Bismuth Subsalicylate—ALB—Methotrexate—testicular cancer	0.051	0.0826	CbGbCtD
Bismuth Subsalicylate—TF—semen—testicular cancer	0.0422	0.254	CbGeAlD
Bismuth Subsalicylate—TF—embryo—testicular cancer	0.00952	0.0573	CbGeAlD
Bismuth Subsalicylate—TF—gonad—testicular cancer	0.00646	0.0389	CbGeAlD
Bismuth Subsalicylate—TF—female gonad—testicular cancer	0.00525	0.0316	CbGeAlD
Bismuth Subsalicylate—TF—testis—testicular cancer	0.00466	0.028	CbGeAlD
Bismuth Subsalicylate—TF—lymph node—testicular cancer	0.00338	0.0203	CbGeAlD
Bismuth Subsalicylate—PTGS2—embryo—testicular cancer	0.0027	0.0162	CbGeAlD
Bismuth Subsalicylate—PTGS1—seminal vesicle—testicular cancer	0.00265	0.016	CbGeAlD
Bismuth Subsalicylate—PTGS2—seminal vesicle—testicular cancer	0.00254	0.0152	CbGeAlD
Bismuth Subsalicylate—ALB—testis—testicular cancer	0.00242	0.0146	CbGeAlD
Bismuth Subsalicylate—Hearing impaired—Ifosfamide—testicular cancer	0.00191	0.00883	CcSEcCtD
Bismuth Subsalicylate—Infection—Carboplatin—testicular cancer	0.00189	0.00875	CcSEcCtD
Bismuth Subsalicylate—Oesophagitis—Dactinomycin—testicular cancer	0.00181	0.00838	CcSEcCtD
Bismuth Subsalicylate—Extravasation—Cisplatin—testicular cancer	0.0018	0.0083	CcSEcCtD
Bismuth Subsalicylate—Phlebitis—Bleomycin—testicular cancer	0.00179	0.00828	CcSEcCtD
Bismuth Subsalicylate—ALB—lymph node—testicular cancer	0.00176	0.0106	CbGeAlD
Bismuth Subsalicylate—Skin exfoliation—Ifosfamide—testicular cancer	0.00174	0.00802	CcSEcCtD
Bismuth Subsalicylate—Phlebitis—Dactinomycin—testicular cancer	0.00167	0.00772	CcSEcCtD
Bismuth Subsalicylate—Hearing impaired—Cisplatin—testicular cancer	0.00165	0.00761	CcSEcCtD
Bismuth Subsalicylate—Extravasation—Etoposide—testicular cancer	0.00165	0.0076	CcSEcCtD
Bismuth Subsalicylate—Pain—Carboplatin—testicular cancer	0.00163	0.00753	CcSEcCtD
Bismuth Subsalicylate—PTGS1—female gonad—testicular cancer	0.00156	0.00937	CbGeAlD
Bismuth Subsalicylate—Phlebitis—Ifosfamide—testicular cancer	0.00153	0.00708	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Carboplatin—testicular cancer	0.00151	0.00696	CcSEcCtD
Bismuth Subsalicylate—Skin exfoliation—Cisplatin—testicular cancer	0.0015	0.00691	CcSEcCtD
Bismuth Subsalicylate—Venous thrombosis—Epirubicin—testicular cancer	0.00149	0.00689	CcSEcCtD
Bismuth Subsalicylate—PTGS2—female gonad—testicular cancer	0.00149	0.00895	CbGeAlD
Bismuth Subsalicylate—Deafness—Ifosfamide—testicular cancer	0.00147	0.00682	CcSEcCtD
Bismuth Subsalicylate—Lethargy—Dactinomycin—testicular cancer	0.00147	0.00679	CcSEcCtD
Bismuth Subsalicylate—Gastric ulcer—Epirubicin—testicular cancer	0.00138	0.0064	CcSEcCtD
Bismuth Subsalicylate—PTGS1—testis—testicular cancer	0.00138	0.00831	CbGeAlD
Bismuth Subsalicylate—Venous thrombosis—Doxorubicin—testicular cancer	0.00138	0.00638	CcSEcCtD
Bismuth Subsalicylate—Hallucination—Chlorambucil—testicular cancer	0.00137	0.00635	CcSEcCtD
Bismuth Subsalicylate—Skin exfoliation—Etoposide—testicular cancer	0.00137	0.00633	CcSEcCtD
Bismuth Subsalicylate—Phlebitis—Cisplatin—testicular cancer	0.00132	0.0061	CcSEcCtD
Bismuth Subsalicylate—Oesophagitis—Etoposide—testicular cancer	0.00131	0.00606	CcSEcCtD
Bismuth Subsalicylate—Erythema multiforme—Chlorambucil—testicular cancer	0.0013	0.00603	CcSEcCtD
Bismuth Subsalicylate—Gastric ulcer—Doxorubicin—testicular cancer	0.00128	0.00592	CcSEcCtD
Bismuth Subsalicylate—Deafness—Cisplatin—testicular cancer	0.00127	0.00588	CcSEcCtD
Bismuth Subsalicylate—Burning sensation—Methotrexate—testicular cancer	0.00124	0.00572	CcSEcCtD
Bismuth Subsalicylate—Lung disorder—Methotrexate—testicular cancer	0.00121	0.00562	CcSEcCtD
Bismuth Subsalicylate—Phlebitis—Etoposide—testicular cancer	0.00121	0.00559	CcSEcCtD
Bismuth Subsalicylate—Burning sensation—Epirubicin—testicular cancer	0.00116	0.00535	CcSEcCtD
Bismuth Subsalicylate—Hyponatraemia—Cisplatin—testicular cancer	0.00114	0.00528	CcSEcCtD
Bismuth Subsalicylate—Lung disorder—Epirubicin—testicular cancer	0.00114	0.00525	CcSEcCtD
Bismuth Subsalicylate—Burning sensation—Doxorubicin—testicular cancer	0.00107	0.00495	CcSEcCtD
Bismuth Subsalicylate—Lung disorder—Doxorubicin—testicular cancer	0.00105	0.00486	CcSEcCtD
Bismuth Subsalicylate—PTGS1—lymph node—testicular cancer	0.001	0.00602	CbGeAlD
Bismuth Subsalicylate—Hepatitis—Dactinomycin—testicular cancer	0.000996	0.0046	CcSEcCtD
Bismuth Subsalicylate—Stinging—Epirubicin—testicular cancer	0.000993	0.00459	CcSEcCtD
Bismuth Subsalicylate—Confusional state—Chlorambucil—testicular cancer	0.000988	0.00457	CcSEcCtD
Bismuth Subsalicylate—Extravasation—Methotrexate—testicular cancer	0.000986	0.00456	CcSEcCtD
Bismuth Subsalicylate—Infection—Chlorambucil—testicular cancer	0.000974	0.0045	CcSEcCtD
Bismuth Subsalicylate—PTGS2—lymph node—testicular cancer	0.000957	0.00576	CbGeAlD
Bismuth Subsalicylate—Abdominal discomfort—Cisplatin—testicular cancer	0.000942	0.00436	CcSEcCtD
Bismuth Subsalicylate—Erythema multiforme—Dactinomycin—testicular cancer	0.000942	0.00435	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Chlorambucil—testicular cancer	0.000934	0.00432	CcSEcCtD
Bismuth Subsalicylate—Erythema—Bleomycin—testicular cancer	0.00093	0.0043	CcSEcCtD
Bismuth Subsalicylate—Extravasation—Epirubicin—testicular cancer	0.000922	0.00426	CcSEcCtD
Bismuth Subsalicylate—Stinging—Doxorubicin—testicular cancer	0.000919	0.00425	CcSEcCtD
Bismuth Subsalicylate—Hepatitis—Ifosfamide—testicular cancer	0.000913	0.00422	CcSEcCtD
Bismuth Subsalicylate—Hallucination—Ifosfamide—testicular cancer	0.000908	0.0042	CcSEcCtD
Bismuth Subsalicylate—Erythema—Dactinomycin—testicular cancer	0.000867	0.00401	CcSEcCtD
Bismuth Subsalicylate—Erythema multiforme—Ifosfamide—testicular cancer	0.000863	0.00399	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Chlorambucil—testicular cancer	0.000863	0.00399	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Vinblastine—testicular cancer	0.000856	0.00396	CcSEcCtD
Bismuth Subsalicylate—Extravasation—Doxorubicin—testicular cancer	0.000853	0.00394	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Chlorambucil—testicular cancer	0.000852	0.00394	CcSEcCtD
Bismuth Subsalicylate—Tinnitus—Ifosfamide—testicular cancer	0.000851	0.00393	CcSEcCtD
Bismuth Subsalicylate—Pain—Chlorambucil—testicular cancer	0.000838	0.00387	CcSEcCtD
Bismuth Subsalicylate—Skin exfoliation—Methotrexate—testicular cancer	0.000821	0.00379	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Chlorambucil—testicular cancer	0.000808	0.00373	CcSEcCtD
Bismuth Subsalicylate—Erythema—Ifosfamide—testicular cancer	0.000795	0.00367	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Vinblastine—testicular cancer	0.000781	0.00361	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Chlorambucil—testicular cancer	0.000779	0.0036	CcSEcCtD
Bismuth Subsalicylate—Ecchymosis—Methotrexate—testicular cancer	0.000777	0.00359	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Chlorambucil—testicular cancer	0.000775	0.00358	CcSEcCtD
Bismuth Subsalicylate—Pain—Vinblastine—testicular cancer	0.000768	0.00355	CcSEcCtD
Bismuth Subsalicylate—Constipation—Vinblastine—testicular cancer	0.000768	0.00355	CcSEcCtD
Bismuth Subsalicylate—Skin exfoliation—Epirubicin—testicular cancer	0.000768	0.00355	CcSEcCtD
Bismuth Subsalicylate—Confusional state—Bleomycin—testicular cancer	0.000765	0.00354	CcSEcCtD
Bismuth Subsalicylate—Oedema—Bleomycin—testicular cancer	0.000759	0.00351	CcSEcCtD
Bismuth Subsalicylate—Infection—Bleomycin—testicular cancer	0.000754	0.00348	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Vinblastine—testicular cancer	0.00074	0.00342	CcSEcCtD
Bismuth Subsalicylate—Oesophagitis—Epirubicin—testicular cancer	0.000735	0.0034	CcSEcCtD
Bismuth Subsalicylate—Tinnitus—Cisplatin—testicular cancer	0.000734	0.00339	CcSEcCtD
Bismuth Subsalicylate—Ecchymosis—Epirubicin—testicular cancer	0.000728	0.00336	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Bleomycin—testicular cancer	0.000723	0.00334	CcSEcCtD
Bismuth Subsalicylate—Skin exfoliation—Doxorubicin—testicular cancer	0.000711	0.00329	CcSEcCtD
Bismuth Subsalicylate—Oedema—Dactinomycin—testicular cancer	0.000708	0.00327	CcSEcCtD
Bismuth Subsalicylate—Infection—Dactinomycin—testicular cancer	0.000703	0.00325	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Chlorambucil—testicular cancer	0.000694	0.00321	CcSEcCtD
Bismuth Subsalicylate—Erythema—Cisplatin—testicular cancer	0.000685	0.00317	CcSEcCtD
Bismuth Subsalicylate—Erythema multiforme—Etoposide—testicular cancer	0.000682	0.00315	CcSEcCtD
Bismuth Subsalicylate—Oesophagitis—Doxorubicin—testicular cancer	0.00068	0.00314	CcSEcCtD
Bismuth Subsalicylate—Phlebitis—Epirubicin—testicular cancer	0.000678	0.00313	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Dactinomycin—testicular cancer	0.000675	0.00312	CcSEcCtD
Bismuth Subsalicylate—Ecchymosis—Doxorubicin—testicular cancer	0.000673	0.00311	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Chlorambucil—testicular cancer	0.000671	0.0031	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Bleomycin—testicular cancer	0.00066	0.00305	CcSEcCtD
Bismuth Subsalicylate—Confusional state—Ifosfamide—testicular cancer	0.000654	0.00302	CcSEcCtD
Bismuth Subsalicylate—Pain—Bleomycin—testicular cancer	0.000649	0.003	CcSEcCtD
Bismuth Subsalicylate—Oedema—Ifosfamide—testicular cancer	0.000648	0.003	CcSEcCtD
Bismuth Subsalicylate—Infection—Ifosfamide—testicular cancer	0.000644	0.00298	CcSEcCtD
Bismuth Subsalicylate—Lethargy—Methotrexate—testicular cancer	0.000637	0.00294	CcSEcCtD
Bismuth Subsalicylate—Phlebitis—Doxorubicin—testicular cancer	0.000627	0.0029	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Bleomycin—testicular cancer	0.000625	0.00289	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Chlorambucil—testicular cancer	0.000623	0.00288	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Ifosfamide—testicular cancer	0.000618	0.00286	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Dactinomycin—testicular cancer	0.000615	0.00284	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Vinblastine—testicular cancer	0.000615	0.00284	CcSEcCtD
Bismuth Subsalicylate—Dysgeusia—Etoposide—testicular cancer	0.000615	0.00284	CcSEcCtD
Bismuth Subsalicylate—Pain—Dactinomycin—testicular cancer	0.000605	0.0028	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Bleomycin—testicular cancer	0.000603	0.00279	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Bleomycin—testicular cancer	0.0006	0.00277	CcSEcCtD
Bismuth Subsalicylate—Lethargy—Epirubicin—testicular cancer	0.000596	0.00276	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Vinblastine—testicular cancer	0.000594	0.00275	CcSEcCtD
Bismuth Subsalicylate—Hyponatraemia—Epirubicin—testicular cancer	0.000586	0.00271	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Dactinomycin—testicular cancer	0.000583	0.0027	CcSEcCtD
Bismuth Subsalicylate—Nausea—Chlorambucil—testicular cancer	0.000582	0.00269	CcSEcCtD
Bismuth Subsalicylate—Somnolence—Ifosfamide—testicular cancer	0.000576	0.00266	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Vinblastine—testicular cancer	0.000571	0.00264	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Ifosfamide—testicular cancer	0.000564	0.00261	CcSEcCtD
Bismuth Subsalicylate—Headache—Vinblastine—testicular cancer	0.000563	0.0026	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Dactinomycin—testicular cancer	0.000559	0.00259	CcSEcCtD
Bismuth Subsalicylate—Oedema—Cisplatin—testicular cancer	0.000559	0.00258	CcSEcCtD
Bismuth Subsalicylate—Infection—Cisplatin—testicular cancer	0.000555	0.00257	CcSEcCtD
Bismuth Subsalicylate—Constipation—Ifosfamide—testicular cancer	0.000555	0.00256	CcSEcCtD
Bismuth Subsalicylate—Pain—Ifosfamide—testicular cancer	0.000555	0.00256	CcSEcCtD
Bismuth Subsalicylate—Lethargy—Doxorubicin—testicular cancer	0.000552	0.00255	CcSEcCtD
Bismuth Subsalicylate—Hyponatraemia—Doxorubicin—testicular cancer	0.000543	0.00251	CcSEcCtD
Bismuth Subsalicylate—Asthma—Methotrexate—testicular cancer	0.000539	0.00249	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Bleomycin—testicular cancer	0.000537	0.00248	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Ifosfamide—testicular cancer	0.000534	0.00247	CcSEcCtD
Bismuth Subsalicylate—Nausea—Vinblastine—testicular cancer	0.000534	0.00247	CcSEcCtD
Bismuth Subsalicylate—Abdominal pain upper—Epirubicin—testicular cancer	0.000533	0.00247	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Cisplatin—testicular cancer	0.000533	0.00246	CcSEcCtD
Bismuth Subsalicylate—Abdominal discomfort—Methotrexate—testicular cancer	0.000517	0.00239	CcSEcCtD
Bismuth Subsalicylate—Confusional state—Etoposide—testicular cancer	0.000516	0.00239	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Ifosfamide—testicular cancer	0.000515	0.00238	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Ifosfamide—testicular cancer	0.000513	0.00237	CcSEcCtD
Bismuth Subsalicylate—Infection—Etoposide—testicular cancer	0.000509	0.00235	CcSEcCtD
Bismuth Subsalicylate—Asthma—Epirubicin—testicular cancer	0.000505	0.00233	CcSEcCtD
Bismuth Subsalicylate—Abdominal pain upper—Doxorubicin—testicular cancer	0.000494	0.00228	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Etoposide—testicular cancer	0.000488	0.00226	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Cisplatin—testicular cancer	0.000486	0.00225	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Dactinomycin—testicular cancer	0.000484	0.00224	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Bleomycin—testicular cancer	0.000482	0.00223	CcSEcCtD
Bismuth Subsalicylate—Drowsiness—Methotrexate—testicular cancer	0.000481	0.00222	CcSEcCtD
Bismuth Subsalicylate—Rash—Bleomycin—testicular cancer	0.000478	0.00221	CcSEcCtD
Bismuth Subsalicylate—Pain—Cisplatin—testicular cancer	0.000478	0.00221	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Bleomycin—testicular cancer	0.000478	0.00221	CcSEcCtD
Bismuth Subsalicylate—Asthma—Doxorubicin—testicular cancer	0.000467	0.00216	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Cisplatin—testicular cancer	0.000461	0.00213	CcSEcCtD
Bismuth Subsalicylate—Weight increased—Epirubicin—testicular cancer	0.000459	0.00212	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Ifosfamide—testicular cancer	0.000459	0.00212	CcSEcCtD
Bismuth Subsalicylate—Somnolence—Etoposide—testicular cancer	0.000455	0.0021	CcSEcCtD
Bismuth Subsalicylate—Epistaxis—Methotrexate—testicular cancer	0.000454	0.0021	CcSEcCtD
Bismuth Subsalicylate—Nausea—Bleomycin—testicular cancer	0.000451	0.00208	CcSEcCtD
Bismuth Subsalicylate—Drowsiness—Epirubicin—testicular cancer	0.00045	0.00208	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Dactinomycin—testicular cancer	0.00045	0.00208	CcSEcCtD
Bismuth Subsalicylate—Rash—Dactinomycin—testicular cancer	0.000446	0.00206	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Etoposide—testicular cancer	0.000445	0.00206	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Ifosfamide—testicular cancer	0.000444	0.00205	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Cisplatin—testicular cancer	0.000442	0.00204	CcSEcCtD
Bismuth Subsalicylate—Pain—Etoposide—testicular cancer	0.000438	0.00202	CcSEcCtD
Bismuth Subsalicylate—Constipation—Etoposide—testicular cancer	0.000438	0.00202	CcSEcCtD
Bismuth Subsalicylate—Hepatitis—Methotrexate—testicular cancer	0.000432	0.002	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Ifosfamide—testicular cancer	0.000429	0.00198	CcSEcCtD
Bismuth Subsalicylate—Weight increased—Doxorubicin—testicular cancer	0.000425	0.00196	CcSEcCtD
Bismuth Subsalicylate—Epistaxis—Epirubicin—testicular cancer	0.000425	0.00196	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Etoposide—testicular cancer	0.000422	0.00195	CcSEcCtD
Bismuth Subsalicylate—Nausea—Dactinomycin—testicular cancer	0.00042	0.00194	CcSEcCtD
Bismuth Subsalicylate—Drowsiness—Doxorubicin—testicular cancer	0.000416	0.00193	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Ifosfamide—testicular cancer	0.000412	0.00191	CcSEcCtD
Bismuth Subsalicylate—Rash—Ifosfamide—testicular cancer	0.000409	0.00189	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Ifosfamide—testicular cancer	0.000408	0.00189	CcSEcCtD
Bismuth Subsalicylate—Erythema multiforme—Methotrexate—testicular cancer	0.000408	0.00189	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Etoposide—testicular cancer	0.000407	0.00188	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Etoposide—testicular cancer	0.000405	0.00187	CcSEcCtD
Bismuth Subsalicylate—Hepatitis—Epirubicin—testicular cancer	0.000404	0.00187	CcSEcCtD
Bismuth Subsalicylate—Tinnitus—Methotrexate—testicular cancer	0.000403	0.00186	CcSEcCtD
Bismuth Subsalicylate—Epistaxis—Doxorubicin—testicular cancer	0.000393	0.00182	CcSEcCtD
Bismuth Subsalicylate—Nausea—Ifosfamide—testicular cancer	0.000385	0.00178	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Cisplatin—testicular cancer	0.000383	0.00177	CcSEcCtD
Bismuth Subsalicylate—Erythema multiforme—Epirubicin—testicular cancer	0.000382	0.00177	CcSEcCtD
Bismuth Subsalicylate—Tinnitus—Epirubicin—testicular cancer	0.000377	0.00174	CcSEcCtD
Bismuth Subsalicylate—Erythema—Methotrexate—testicular cancer	0.000376	0.00174	CcSEcCtD
Bismuth Subsalicylate—Hepatitis—Doxorubicin—testicular cancer	0.000374	0.00173	CcSEcCtD
Bismuth Subsalicylate—Dysgeusia—Methotrexate—testicular cancer	0.000368	0.0017	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Etoposide—testicular cancer	0.000362	0.00167	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Cisplatin—testicular cancer	0.000355	0.00164	CcSEcCtD
Bismuth Subsalicylate—Erythema multiforme—Doxorubicin—testicular cancer	0.000354	0.00163	CcSEcCtD
Bismuth Subsalicylate—Rash—Cisplatin—testicular cancer	0.000352	0.00163	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Cisplatin—testicular cancer	0.000352	0.00163	CcSEcCtD
Bismuth Subsalicylate—Erythema—Epirubicin—testicular cancer	0.000352	0.00163	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Etoposide—testicular cancer	0.00035	0.00162	CcSEcCtD
Bismuth Subsalicylate—Tinnitus—Doxorubicin—testicular cancer	0.000349	0.00161	CcSEcCtD
Bismuth Subsalicylate—Dysgeusia—Epirubicin—testicular cancer	0.000344	0.00159	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Etoposide—testicular cancer	0.000339	0.00157	CcSEcCtD
Bismuth Subsalicylate—Nausea—Cisplatin—testicular cancer	0.000332	0.00153	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Etoposide—testicular cancer	0.000326	0.00151	CcSEcCtD
Bismuth Subsalicylate—Erythema—Doxorubicin—testicular cancer	0.000325	0.0015	CcSEcCtD
Bismuth Subsalicylate—Rash—Etoposide—testicular cancer	0.000323	0.00149	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Etoposide—testicular cancer	0.000323	0.00149	CcSEcCtD
Bismuth Subsalicylate—Headache—Etoposide—testicular cancer	0.000321	0.00148	CcSEcCtD
Bismuth Subsalicylate—Dysgeusia—Doxorubicin—testicular cancer	0.000319	0.00147	CcSEcCtD
Bismuth Subsalicylate—Confusional state—Methotrexate—testicular cancer	0.000309	0.00143	CcSEcCtD
Bismuth Subsalicylate—Infection—Methotrexate—testicular cancer	0.000305	0.00141	CcSEcCtD
Bismuth Subsalicylate—Nausea—Etoposide—testicular cancer	0.000304	0.00141	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Methotrexate—testicular cancer	0.000292	0.00135	CcSEcCtD
Bismuth Subsalicylate—Confusional state—Epirubicin—testicular cancer	0.000289	0.00134	CcSEcCtD
Bismuth Subsalicylate—Oedema—Epirubicin—testicular cancer	0.000287	0.00133	CcSEcCtD
Bismuth Subsalicylate—Infection—Epirubicin—testicular cancer	0.000285	0.00132	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Epirubicin—testicular cancer	0.000274	0.00126	CcSEcCtD
Bismuth Subsalicylate—Somnolence—Methotrexate—testicular cancer	0.000273	0.00126	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Methotrexate—testicular cancer	0.00027	0.00125	CcSEcCtD
Bismuth Subsalicylate—Confusional state—Doxorubicin—testicular cancer	0.000268	0.00124	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Methotrexate—testicular cancer	0.000267	0.00123	CcSEcCtD
Bismuth Subsalicylate—Oedema—Doxorubicin—testicular cancer	0.000266	0.00123	CcSEcCtD
Bismuth Subsalicylate—Infection—Doxorubicin—testicular cancer	0.000264	0.00122	CcSEcCtD
Bismuth Subsalicylate—Pain—Methotrexate—testicular cancer	0.000262	0.00121	CcSEcCtD
Bismuth Subsalicylate—Somnolence—Epirubicin—testicular cancer	0.000255	0.00118	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Doxorubicin—testicular cancer	0.000253	0.00117	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Methotrexate—testicular cancer	0.000253	0.00117	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Epirubicin—testicular cancer	0.000253	0.00117	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Epirubicin—testicular cancer	0.00025	0.00115	CcSEcCtD
Bismuth Subsalicylate—Pain—Epirubicin—testicular cancer	0.000246	0.00113	CcSEcCtD
Bismuth Subsalicylate—Constipation—Epirubicin—testicular cancer	0.000246	0.00113	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Methotrexate—testicular cancer	0.000244	0.00113	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Methotrexate—testicular cancer	0.000243	0.00112	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Epirubicin—testicular cancer	0.000237	0.00109	CcSEcCtD
Bismuth Subsalicylate—Somnolence—Doxorubicin—testicular cancer	0.000236	0.00109	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Doxorubicin—testicular cancer	0.000234	0.00108	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Doxorubicin—testicular cancer	0.000231	0.00107	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Epirubicin—testicular cancer	0.000228	0.00105	CcSEcCtD
Bismuth Subsalicylate—Pain—Doxorubicin—testicular cancer	0.000227	0.00105	CcSEcCtD
Bismuth Subsalicylate—Constipation—Doxorubicin—testicular cancer	0.000227	0.00105	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Epirubicin—testicular cancer	0.000227	0.00105	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Doxorubicin—testicular cancer	0.000219	0.00101	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Methotrexate—testicular cancer	0.000217	0.001	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Doxorubicin—testicular cancer	0.000211	0.000975	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Doxorubicin—testicular cancer	0.00021	0.000971	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Methotrexate—testicular cancer	0.00021	0.00097	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Epirubicin—testicular cancer	0.000203	0.000939	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Methotrexate—testicular cancer	0.000203	0.000938	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Epirubicin—testicular cancer	0.000196	0.000908	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Methotrexate—testicular cancer	0.000195	0.000902	CcSEcCtD
Bismuth Subsalicylate—Rash—Methotrexate—testicular cancer	0.000193	0.000894	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Methotrexate—testicular cancer	0.000193	0.000893	CcSEcCtD
Bismuth Subsalicylate—Headache—Methotrexate—testicular cancer	0.000192	0.000888	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Epirubicin—testicular cancer	0.00019	0.000877	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Doxorubicin—testicular cancer	0.000188	0.000869	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Epirubicin—testicular cancer	0.000183	0.000844	CcSEcCtD
Bismuth Subsalicylate—Nausea—Methotrexate—testicular cancer	0.000182	0.000842	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Doxorubicin—testicular cancer	0.000182	0.00084	CcSEcCtD
Bismuth Subsalicylate—Rash—Epirubicin—testicular cancer	0.000181	0.000837	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Epirubicin—testicular cancer	0.000181	0.000836	CcSEcCtD
Bismuth Subsalicylate—Headache—Epirubicin—testicular cancer	0.00018	0.000831	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Doxorubicin—testicular cancer	0.000176	0.000812	CcSEcCtD
Bismuth Subsalicylate—Nausea—Epirubicin—testicular cancer	0.000171	0.000788	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Doxorubicin—testicular cancer	0.000169	0.000781	CcSEcCtD
Bismuth Subsalicylate—Rash—Doxorubicin—testicular cancer	0.000167	0.000774	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Doxorubicin—testicular cancer	0.000167	0.000773	CcSEcCtD
Bismuth Subsalicylate—Headache—Doxorubicin—testicular cancer	0.000166	0.000769	CcSEcCtD
Bismuth Subsalicylate—Nausea—Doxorubicin—testicular cancer	0.000158	0.000729	CcSEcCtD
